Docket
15/75,697,
U.S. Patent Application
(Mar. 21, 2016)
Cite Docket
BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES, 15/75,697 (U.S. Pat. App.)
+ More Snippets
Docket
15/47,388,
U.S. Patent Application
(Feb. 18, 2016)
Cite Docket
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 15/47,388 (U.S. Pat. App.)
+ More Snippets
Docket
15/9,468,
U.S. Patent Application
(Jan. 28, 2016)
Cite Docket
METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET, 15/9,468 (U.S. Pat. App.)
+ More Snippets
Docket
15/9,480,
U.S. Patent Application
(Jan. 28, 2016)
Cite Docket
METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET, 15/9,480 (U.S. Pat. App.)
+ More Snippets
Docket
14/872,226,
U.S. Patent Application
(Oct. 1, 2015)
Cite Docket
METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET, 14/872,226 (U.S. Pat. App.)
+ More Snippets
Docket
14/863,784,
U.S. Patent Application
(Sept. 24, 2015)
Cite Docket
BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES, 14/863,784 (U.S. Pat. App.)
+ More Snippets
Docket
14/735,526,
U.S. Patent Application
(June 10, 2015)
Cite Docket
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 14/735,526 (U.S. Pat. App.)
+ More Snippets
Docket
14/657,151,
U.S. Patent Application
(March 13, 2015)
Cite Docket
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product, 14/657,151 (U.S. Pat. App.)
+ More Snippets
Docket
14/624,998,
U.S. Patent Application
(Feb. 18, 2015)
Cite Docket
METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET, 14/624,998 (U.S. Pat. App.)
+ More Snippets
Document
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 16/928,739, No. 1-17-US-169287390UP1 (U.S. Pat. App. Mar. 1, 2022)
Cite Document
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 16/928,739, No. 1-17-US-169287390UP1 (U.S. Pat. App. Mar. 1, 2022)
+ More Snippets
Docket
14/554,123,
U.S. Patent Application
(Nov. 26, 2014)
Cite Docket
ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT, 14/554,123 (U.S. Pat. App.)
+ More Snippets
Document
PHARMACEUTICAL COMPOSITIONS COMPRISING A FLOATING INTERPENETRATING POLYMER NETWORK FORMING SYSTEM, 16/955,373, No. 1-19-US-169553730RP1 (U.S. Pat. App. N...
Cite Document
PHARMACEUTICAL COMPOSITIONS COMPRISING A FLOATING INTERPENETRATING POLYMER NETWORK FORMING SYSTEM, 16/955,373, No. 1-19-US-169553730RP1 (U.S. Pat. App. Nov. 10, 2021)
+ More Snippets
Docket
14/508,613,
U.S. Patent Application
(Oct. 7, 2014)
Cite Docket
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes, 14/508,613 (U.S. Pat. App.)
+ More Snippets
Document
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 16/928,739, No. 1-14-US-169287390MP1 (U.S. Pat. App. Aug. 9, 2021)
Cite Document
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES, 16/928,739, No. 1-14-US-169287390MP1 (U.S. Pat. App. Aug. 9, 2021)
+ More Snippets
Document
MODIFIED RELEASE DRUG POWDER COMPOSITION COMPRISING GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE, 16/955,377, No. 1-19-US...
Cite Document
MODIFIED RELEASE DRUG POWDER COMPOSITION COMPRISING GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE, 16/955,377, No. 1-19-US-169553770MP1 (U.S. Pat. App. Jul. 7, 2021)
+ More Snippets